Cargando…
Safety of PEGylated recombinant human full‐length coagulation factor VIII (BAX 855) in the overall context of PEG and PEG conjugates
INTRODUCTION: BAX 855 is a PEGylated human full‐length recombinant factor VIII (rFVIII) based on licensed rFVIII (ADVATE). The applied PEGylation technology has been optimized to retain functionality of the FVIII molecule, improve its pharmacokinetic properties and allow less frequent injections whi...
Autores principales: | Stidl, R., Fuchs, S., Bossard, M., Siekmann, J., Turecek, P. L., Putz, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737295/ https://www.ncbi.nlm.nih.gov/pubmed/26219204 http://dx.doi.org/10.1111/hae.12762 |
Ejemplares similares
-
Data on the removal of peroxides from functionalized polyethylene glycol (PEG) and effects on the stability and sensitivity of resulting PEGylated conjugates
por: Babity, Samuel, et al.
Publicado: (2020) -
Synthesis of Acid-Labile PEG and PEG-Doxorubicin-Conjugate Nanoparticles via Brush-First
ROMP
por: Gao, Angela X., et al.
Publicado: (2014) -
PEGylation of Goldbody: PEG-aided conformational engineering of peptides on gold nanoparticles
por: Gao, Tiange, et al.
Publicado: (2022) -
PEG Conjugated Zein Nanoparticles for In Vivo Use
por: van Ballegooie, Courtney, et al.
Publicado: (2022) -
Synthesis, physicochemical characterization, toxicity and efficacy of a PEG conjugate and a hybrid PEG conjugate nanoparticle formulation of the antibiotic moxifloxacin
por: Tshweu, Lesego L., et al.
Publicado: (2020)